0 results available. Select is focused ,type to refine list, press Down to open the menu,
No data available
No data available
No data available
No data available
The chart above depicts the distribution of ev / fwd ebitda - capex for companies operating in the Healthcare sector in the Developed economic region. Over 1,870 companies were considered in this analysis, and 1,797 had meaningful values. The average ev / fwd ebitda - capex of companies in the sector is -53.8x with a standard deviation of 224.6x.
Inozyme Pharma Inc's EV / Fwd EBITDA - CAPEX of -18.6x ranks in the 26.6% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,871 |
| Included Constituents | 1,797 |
| Min | -2,092.1x |
| Max | 422.6x |
| Median | -1.8x |
| Mean | -53.8x |
| Standard Deviation | 224.6x |
You can find companies with similar ev / fwd ebitda - capex using this stock screener.